Regeneron Pharmaceuticals Q4 2024 Earnings Preview Regeneron Pharmaceuticals Q4 2024 Earnings Preview Post ContentregnRead More You might also be interested in reading Surmodics GAAP EPS of -$0.37, revenue of $29.5M. February 3, 2025 In Mainstream ← Previous post Next post →